To print: Select File and then Print from your browser's menu

Title: Scanner-Assisted Carbon Dioxide Laser Surgery Effective For Hidradenitis Suppurativa

URL: http://www2.us.elsevierhealth.com/scripts/om.dll/serve?acti
ion=searchDB&searchDBfor=art&artType=abs&id=a124601&nav=abs

J Am Acad Dermatol 2002; 47:280-285 "Scanner-assisted carbon dioxide laser surgery: A retrospective follow-up study of patients with hidradenitis suppurativa"
08/26/2002 03:32:14 PM
By James Adams

Surgery using the carbon dioxide laser rapid-beam optomechanical scanner system is fast, efficient and well accepted by patients with hidradenitis suppurativa. Hidradenitis suppurativa has chronic fistulating lesions that spread by contiguous growth. Effective surgical treatment requires removal of all affected tissue, explain investigators from the the Karolinska Institute at Huddinge University Hospital in Stockholm, Sweden. They evaluated scanner-assisted carbon dioxide laser surgery in 34 patients with Hurley stage II hidradenitis suppurativa. Patients were of a mean age of 33.9 years and had had hidradenitis for a mean 13.4 years. They all had experienced more than three recurrences of suppurating lesions in year preceding the study. Thirty-one of the patients were women. Follow-up after surgery ranged from seven to 87 months with the mean follow-up period being 34.5 months. Mean time to healing was four weeks. Four patients experienced recurrences at the surgical site during follow-up. Thirty patients had no recurrences at the surgical site. However, 12 patients developed suppurating lesions that were separated from the surgical site by at least five centimeters and 25 patients experienced flares of lesions in areas other than the treatment site. Eight patients had no recurrences at all. The investigators conclude that macroscopically controlled tissue-selective carbon dioxide laser surgery is an appropriate treatment for hidradenitis suppurativa. Funds for this research were provided by the Finsen Foundation and the Edvard Welander Foundation.

http://www2.us.elsevierhealth.com/scripts/om.dll/serve?acti
ion=searchDB&searchDBfor=art&artType=abs&id=a124601&nav=abs

Copyright © 2009 P\S\L Consulting Group Inc. All rights reserved. Republication or redistribution of P\S\L content is expressly prohibited without the prior written consent of P\S\L. P\S\L shall not be liable for any errors, omissions or delays in this content or any other content on its sites, newsletters or other publications, nor for any decisions or actions taken in reliance on such content.